# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-023043
Filing Date
2024-04-29
Accepted
2024-04-29 16:43:11
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | ny20023925x4_defa14a.htm | DEFA14A | 8203
2 |  | ny20023925x4_nc01.jpg | GRAPHIC | 355907
3 |  | ny20023925x4_nc02.jpg | GRAPHIC | 337890
| Complete submission text file | 0001140361-24-023043.txt |  | 965209

Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36829 | Film No.: 24891928
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)